Gene · 5921
Papers3,549
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,549
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CD200 as a Potential New Player in Inflammation during Rotator Cuff Tendon Injury/Repair: An In Vitro Model. | Int J Mol Sci | 2022 | 36499497 | PubTator, text mining | PubMed |
| GRP78 Activity Moderation as a Therapeutic Treatment against Obesity. | Int J Environ Res Public Health | 2022 | 36498048 | PubTator, text mining | PubMed |
| Immunological and Genomic Analysis Reveals Clinically Relevant Distinctions between Angiosarcoma Subgroups. | Cancers (Basel) | 2022 | 36497420 | PubTator, text mining | PubMed |
| Forward Genetic Screens as Tools to Investigate Role and Mechanisms of EMT in Cancer. | Cancers (Basel) | 2022 | 36497409 | PubTator, text mining | PubMed |
| Ayurvedic management through telemedicine of covid hypoxia non-dependent of oxygen support in a patient with chest CT score of 18/25- A case report. | J Ayurveda Integr Med | 2022 | 36473403 | PubTator, text mining | PubMed |
| Impact of SOX2 function and regulation on therapy resistance in bladder cancer. | Front Oncol | 2022 | 36465380 | PubTator, text mining | PubMed |
| CD229 interacts with RASAL3 to activate RAS/ERK pathway in multiple myeloma proliferation. | Aging (Albany NY) | 2022 | 36445333 | PubTator, text mining | PubMed |
| Network Pharmacology and Molecular Docking Analysis on Molecular Targets and Mechanisms of Bushen Hugu Decoction in the Treatment of Malignant Tumor Bone Metastases. | Biomed Res Int | 2022 | 36440359 | PubTator, text mining | PubMed |
| Tandem engagement of phosphotyrosines by the dual SH2 domains of p120RasGAP. | Structure | 2022 | 36417908 | PubTator, text mining | PubMed |
| CD6-mediated inhibition of T cell activation via modulation of Ras. | Cell Commun Signal | 2022 | 36414966 | PubTator, text mining | PubMed |
| Modeling (not so) rare developmental disorders associated with mutations in the protein-tyrosine phosphatase SHP2. | Front Cell Dev Biol | 2022 | 36407105 | PubTator, text mining | PubMed |
| Functional and clinical characteristics of focal adhesion kinases in cancer progression. | Front Cell Dev Biol | 2022 | 36407100 | PubTator, text mining | PubMed |
| Aberrant MAPK Signaling Offers Therapeutic Potential for Treatment of Ovarian Carcinoma. | Onco Targets Ther | 2022 | 36388156 | PubTator, text mining | PubMed |
| Plasma RNA profiling unveils transcriptional signatures associated with resistance to osimertinib in EGFR T790M positive non-small cell lung cancer patients. | Transl Lung Cancer Res | 2022 | 36386450 | PubTator, text mining | PubMed |
| Capillary Malformation-Arteriovenous Malformation Syndrome Due to EPHB4 Gene Mutation: Clinical, Dermoscopic, Ecographic and Histopathological Features. | Indian J Dermatol | 2022 | 36386110 | PubTator, text mining | PubMed |
| Genome-Wide Transcriptional Profiling Reveals PHACTR1 as a Novel Molecular Target of Resveratrol in Endothelial Homeostasis. | Nutrients | 2022 | 36364780 | PubTator, text mining | PubMed |
| Small Non-Coding RNAs in Human Cancer. | Genes (Basel) | 2022 | 36360311 | PubTator, text mining | PubMed |
| Prenatal Genetic Testing in the Era of Next Generation Sequencing: A One-Center Canadian Experience. | Genes (Basel) | 2022 | 36360262 | PubTator, text mining | PubMed |
| The Role of Fusobacterium nucleatum in Colorectal Cancer Cell Proliferation and Migration. | Cancers (Basel) | 2022 | 36358769 | PubTator, text mining | PubMed |
| The Predictive and Prognostic Role of RAS-RAF-MEK-ERK Pathway Alterations in Breast Cancer: Revision of the Literature and Comparison with the Analysis of Cancer Genomic Datasets. | Cancers (Basel) | 2022 | 36358725 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5921/papers?page=25